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Abstract
Background: Drosophila Groucho and its human Transducin-like-Enhancer of Split orthologs
(TLEs) function as transcription co-repressors within the context of Wnt signaling, a pathway with
strong links to cancer. The current model for how Groucho/TLE's modify Wnt signaling is by direct
competition with β-catenin for LEF/TCF binding. The molecular events involved in this competitive
interaction are not defined and the actions of Groucho/TLEs within the context of Wnt-linked
cancer are unknown.
Methods: We used in vitro protein interaction assays with the LEF/TCF family member LEF-1, and
in vivo assays with Wnt reporter plasmids to define Groucho/TLE interaction and repressor
function.
Results: Mapping studies reveal that Groucho/TLE binds two regions in LEF-1. The primary site of
recognition is a 20 amino acid region in the Context Dependent Regulatory domain. An auxiliary
site is in the High Mobility Group DNA binding domain. Mutation of an eight amino acid sequence
within the primary region (RFSHHMIP) results in a loss of Groucho action in a transient reporter
assay. Drosophila Groucho, human TLE-1, and a truncated human TLE isoform Amino-enhancer-of-
split (AES), work equivalently to repress LEF-1•β-catenin transcription in transient reporter assays,
and these actions are sensitive to the HDAC inhibitor Trichostatin A. A survey of Groucho/TLE
action in a panel of six colon cancer cell lines with elevated β-catenin shows that Groucho is not
able to repress transcription in a subset of these cell lines.
Conclusion: Our data shows that Groucho/TLE repression requires two sites of interaction in
LEF-1 and that a central, conserved amino acid sequence within the primary region (F S/T/P/xx y I/
L/V) is critical. Our data also reveals that AES opposes LEF-1 transcription activation and that both
Groucho and AES repression require histone deacetylase activity suggesting multiple steps in
Groucho competition with β-catenin. The variable ability of Groucho/TLE to oppose Wnt signaling
in colon cancer cells suggests there may be defects in one or more of these steps.
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Background
The high mobility group (HMG) LEF/TCF transcription
factors are well established activators and repressors that
act to mediate Wnt signaling, but the details of how these
proteins act on transcription are not complete. All LEF/
TCFs are capable of recruiting the potent co-activator β-
catenin via their N-terminal domain for activation (Figure
1A; [1,2]). Recruitment of β-catenin to target genes nucle-
ates higher order activation complexes consisting of, in a
partial listing, nucleosome modification and remodeling
complexes, such as CBP/p300, SWI/SNF Brg1, Ada2/
Ada3, TTRAP and MLL-I/SET-I [3-8]. In particular, β-cat-
enin recruitment results in chromatin acetylation through
the actions of recruited histone acetyltransferases (HATs).
These recruited complexes positively regulate Wnt target
genes including key cell cycle and cell proliferation genes.
LEF/TCF•β-catenin activation complexes are opposed by
equally complex and multifaceted LEF/TCF￿Groucho
repressor complexes [9,10]. Groucho/TLEs are globally
expressed, highly conserved WD-repeat proteins that
function as transcription repressors [11,12]. Although
Groucho/TLEs lack a DNA binding domain they are
recruited to target gene promoters via direct interaction
with transcription factors (bHLH, Runx, Pax5/BSAP, Six
and LEF/TCFs) through one or more of their five protein
interaction domains (Figure 1B; [12-16]). The C-terminal
WD repeat domain in Groucho/TLE recognizes small
Schematic representation of the LEF-1 and LEF-1 deletion constructs, Groucho and APC Figure 1
Schematic representation of the LEF-1 and LEF-1 deletion constructs, Groucho and APC. A) A LEF-1 protein 
schematic highlights four features: the β-catenin binding domain (βBD; aa1-67), the context dependent regulatory domain 
(CRD; aa67-296), an alternative exon in the CRD (black bar; aa214-241) and the high mobility group DNA binding domain 
(HMG; aa296-384). LEF-1 deletions tested in a GST pulldown assay are also depicted. B) General domain structure of Grou-
cho/TLE proteins and truncated AES isoforms. The Q domain (aa1-132) is required for tetramerization and the GP domain 
interacts with HDACs. Three additional domains of protein-protein interaction are shown: the CcN, SP and WD-repeat 
domains. C) Schematic of Adenomatous polyposis coli (APC) and APC mutations found in Familial Adenomatous Polyposis 
(FAP) cancer cell of type I (DLD-1, SW480, and Colo 320) and type II (HT-29) and Hereditary Non-Polyposis Colon Cancer 
(HNPCC) colon cancer cell lines (LS174T and HCT116) [29,34]. Asterisks indicate nuclear export signals and diamonds indi-
cate nuclear localization signals. The MCR (mutation cluster region) refers to the most common site of truncating mutations 
found in colon cancer. This region overlaps a region comprised of 15 and 20 amino acid repeats that bind beta-catenin. [28,48].BMC Cancer 2009, 9:159 http://www.biomedcentral.com/1471-2407/9/159
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amino acid motifs such as the well-studied pentapeptide
WRPY/W motif through a beta-sheet propeller structure
[17]. Proteins that contain WRPY/W-related motifs
include the HES, Six3, Six2, NK-3 transcription factors and
the Runx family of repressors [12,17-19]. Groucho/TLE
can also recognize the eh1 peptide motif (FxIxxIL) origi-
nally described in the Engrailed (En) transcription factor,
but also found in Pax, Six and other factors [14,20-22].
For LEF/TCFs, the Groucho binding domain has been
assigned to the large central CRD region of the protein
and the HMG DNA binding domain [23,24]. The CRD is
approximately 130 amino acids in length, and is the most
divergent region among the LEF/TCFs. The 88 amino acid
HMG DNA binding domain is the most highly conserved
region (Figure 1). Unlike the majority of identified Grou-
cho interacting factors, no direct site of interaction or
Groucho recognition motif has been found for LEF/TCFs.
To better define Groucho/TLE interactions, we have
delimited regions within LEF-1 that are important for
Groucho binding. Our efforts have identified two interact-
ing regions; the strongest is a sequence in the LEF-1 CRD
(amino acids 241–248), and a second, weaker site of
interaction in the LEF-1 HMG DNA binding domain
(amino acids 296–396).
Groucho/TLE assembles a co-repressor complex with LEF/
TCF factors to inhibit transcription of Wnt target genes.
One component of the co-repressor complex is histone
deacetylase-1 (HDAC1), and chromatin immunoprecipi-
tation assays of LEF-1-based repressor complexes detect
HDAC1 bound to Wnt target genes [5]. HDACs, which
remove acetyl groups from chromatin to silence transcrip-
tion, have been demonstrated to interact with Groucho/
TLEs via the N-terminal GP-domain [25]. Since truncated
Groucho members like Amino terminal Enhancer of Split
(AES; Figure 1B) retain this region, we tested the hypoth-
esis that both LEF￿Groucho and LEF￿AES complexes rely
on HDAC activity in repression. Although some reports
suggest that AES isoforms de-repress transcription, others
have demonstrated that they provide repressive activities
similar to full-length Groucho/TLEs [26,27]. Our findings
show that like Groucho, the human AES family member
uses HDAC activities to repress in vivo.
Just as there are many unknowns concerning Groucho
interactions with LEF/TCFs, the dynamic switch back and
forth between Groucho-based repression complexes and
β-catenin-based activation complexes is not completely
understood. The primary site of β-catenin interaction is
the N-terminus of full-length LEF/TCFs, but an additional
β-catenin interaction domain has been detected in the sec-
ond half of the LEF-1 protein (CRD/HMG region) [24].
Discovery of this second site offers a new way to explain
the observation that β-catenin and Groucho proteins
exhibit mutually exclusive binding patterns in in vitro and
in vivo binding assays. That is, it is proposed that the sec-
ond β-catenin interaction in the CRD/HMG region might
overlap a Groucho/TLE binding domain and compete for
this site to destabilize interactions [24]. These in vitro
observations suggest a model where LEF-1 is converted
from an activator to a repressor by direct displacement of
β-catenin by Groucho [24]. However, in vivo interactions
suggest a more intricate switch. Sierra and colleagues have
provided  in vivo chromatin immunoprecipitation evi-
dence that LEF-1 switches from an activator to a repressor
in a multi-step process mediated by the transient associa-
tion of the tumor suppressor Adenomatous Polyposis
Coli (APC). Transient association of APC with the LEF-
1￿β-catenin complex occurs as β-catenin is released and
before Groucho/TLE binding is detected [5]. Thus, dis-
placement of β-catenin occurs prior to any Groucho asso-
ciation. Since the precise site of Groucho interaction has
never been mapped, these in vitro and in vivo observations
remain unresolved. That APC might be involved in the
exchange between Groucho and β-catenin  in vivo has
importance for Wnt signaling and colon cancer where
APC is either mutated or lost in these tumors, and it
underscores how fundamental the unknowns are for
Groucho interaction with the Wnt signaling pathway.
Here we survey Groucho activity in six colon cancer cell
lines that vary according to APC status and loss of β-cat-
enin binding and nuclear localization motifs (Figure 1C,
[28,29]). We find Groucho activity is compromised in
half of these cell lines.
Groucho/TLE regulation is likely to have important effects
on intestinal cell growth and differentiation but so far no
loss-of-function mutations in TLEs have been reported.
Relatively little is known about the role Groucho/TLE
plays in Wnt signaling within the intestine, and it is espe-
cially understudied within the context of colon cancer.
Our findings provide insight into the mechanisms of
Groucho/TLE mediated repression of the Wnt pathway
and suggest that APC status in colon cancers may play a
role in the dynamic interplay between the high levels of β-
catenin and the ubiquitous Groucho/TLE proteins and
ultimately the lack of repression in cancer.
Methods
Cell lines/Transfections
Colon cancer cell lines, SW480, Colo320, DLD-1, LS174T
and the monkey kidney cells, COS-1 were cultured in
either Dulbecco's modified Eagle's medium (DMEM) or
RPMI-1640 medium, supplemented with 10% Fetal
Bovine Serum (FBS), at 37°C and 5% CO2. COS-1 cells
were transfected with FuGENE 6 (Roche) and cancer cell
lines were transfected with Effectene (Quiagen). For
HDAC inhibition, cells were treated with Trichostatin A
(TSA) (50 ng/mL) for 24 hours.BMC Cancer 2009, 9:159 http://www.biomedcentral.com/1471-2407/9/159
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Plasmids
Mammalian expression and reporter vectors were gener-
ously provided by Dr. Hans Clevers, Hubrecht Laboratory,
Netherlands Institute of Developmental Biology (TOP-
Flash and Groucho), by Dr. Randall Moon, University of
Washington (SuperTOPflash), and by Dr. Takashi
Okamoto Department of Molecular Genetics, Nagoya
City University Medical School (mammalian expression
vector pCMV His-AES). and Dr. Wayne Phillips, Peter
MacCallum Cancer Center, Melbourne, Australia (human
TLE-2 expression vector). The full length human LEF-1
coding sequence cloned between BamHI and NheI in
pEV3S includes 285 bp of the 3' untranslated region of
LEF-1 and is the backbone to all of the LEF-1 deletion con-
structs (see also [30]). Bacterial expression of both the
GST and GST fusion proteins were generated with the
pGEX expression vectors. To construct the GST-Groucho
expression vector, Groucho (Drosophila) coding sequences
were excised from pCDNA3 using BstX I and the over-
hangs filled by a Klenow reaction. The fragment was
inserted in-frame into pGEX3X linearized with SmaI. The
construct was sequenced to verify frame. The LEF-1 Grou-
cho binding sequence substitution mutant (GBS; 241/
248) and downstream substitution mutant 250/255 were
generated via site-directed mutagenesis (Stratagene Proto-
col). The LEF-1 GBS (mutation of AA 241–248) was cre-
ated using the primer sequence 5'-acttccatgtc cggg gtag
cgctagcactagcagccggtcctcctggtccc-3'. The LEF-1 250/255
mutation was created using the primer sequence 5'-
catatgattcccggtgtagcgctagcactagcaactggcatccctcat-3'.
Protein-Protein interaction Assay
Recombinant GST or GST-Groucho was produced in
Escherichia coli strain BL21 and recombinant protein puri-
fied over a GST column (Amersham). Fractions were
eluted, and dialyzed (20 mM Tris-HCl (pH7.9), 1
mMDTT, 10 mM MgCl2, 0.05% Nonidet P-40, 10% glyc-
erol). LEF-1 and LEF-1 deletion constructs were 35S
methionine labeled with the TNT in vitro transcription/
translation system (Promega). GST-tagged proteins were
immobilized on Glutathione sepharose beads (Amer-
sham) for 1 hour at 4°C in lysis buffer (200 mM NaCl,
0.5% Tween 20, 10 mM Tris-Cl and a cocktail of protease
inhibitors). Immobilized protein was incubated with 35S-
LEF-1 labeled proteins in binding buffer (200 mM NaCl,
0.5% NP40, 10 mM Tris-Cl, 5 mM MgCl2 and 0.2% BSA)
for 30 minutes at room temperature. Beads were washed
3 times for 10 minutes at room temperature and then
resuspended in 15 uL of 2× SDS Sample buffer. Eluted
proteins were separated on a 15% SDS- PAGE. For visual-
ization, gels were incubated for 30 minutes at room tem-
perature in EN3Hance solution (Perkin Elmer), washed
for 5 minutes in distilled water, dried, and exposed to
film.
Immunoblotting
For COS-1 cell extracts, COS-1 cultures were transiently
transfected and harvested 48 hours post-transfection.
Cells were resuspended in 2× SDS sample buffer. For west-
ern analysis of TLE expression in colon cancer cells,
extracts were prepared with lysis buffer (50 mM Tris-HCl,
120 mM NaCl, 0.5% NP-40, 8 mM MgCl2, 1 mM DTT,
protease inhibitor cocktail), added to 2× SDS sample
buffer, and balanced to load 35 μg total protein onto the
protein gel. Extracts were separated by SDS-PAGE and
transferred to a nitrocellulose membrane. The transfer
membrane was blocked with 5% milk TTBS (TBS, 20 mM
Tris, 500 mM NaCl, pH 7.5 TTBS, TBS, 0.05% Tween-20,
pH 7.5) solution at room temperature for 30 minutes and
incubated overnight at 4°C with primary antibody (Anti-
His antibody (1:250, Santa Cruz Biotenology), Anti-Myc
antibody (1:1000, Santa Cruz Biotechnology), or Anti-
panTLE rat monoclonal antibody (1:1000) [31]) were
diluted in 1% milk TTBS). The membrane was washed 3
times for 10 minutes in TTBS, followed by incubation
with secondary antibodies (anti-mouse or rabbit IgG anti-
bodies (1:5000, Amersham) or anti-rat IgG (1:50,000))
for 2 hours at room temperature. Blots were washed 3
times in TTBS and developed using ECL kit (Amersham)
and exposed to film.
Results
LEF-1 contains two Groucho binding domains
All LEF/TCFs interact with Groucho/TLE family members,
but a specific site of interaction has yet to be defined
[24,27]. We delimited the sequences important for Grou-
cho binding using an in vitro protein interaction assay
with purified recombinant GST-Groucho protein (Dro-
sophila) and LEF-1 deletion proteins produced via in vitro
translation in the presence of 35S-methionine (Figure 2).
The expected size of recombinant GST-Groucho is 125
kDa, but we recover a 97 kDa protein product (Figure 2B).
Therefore, purification of GST-Groucho results in a pro-
tease stable fusion protein lacking part of the C-terminal
WD-repeat domain but retaining more N-terminal
domains including the Q and GP domains. Since the N-
terminal Q domain has previously been shown to be suf-
ficient for interaction with LEF/TCFs, we proceeded with
this GST-Groucho preparation for a finer mapping of the
recognition region within LEF-1 [24,27]. Schematic repre-
sentations of the LEF-1 deletion mutants tested in the
pull-down assay are shown in Figure 1A. Full length LEF-
1 (1–399) as well as LEF-1 C-terminal deletions, retaining
either the entire CRD (1–296) or N-terminal portions of
the CRD (1–276 and 1–256), are all able to specifically
interact with GST-Groucho (Figure 2A, middle panel,
lanes 1–4). However, a LEF-1 internal deletion lacking the
C-terminal half of the CRD and the entire HMG DNA
binding domain (Δ237–396) does not interact with GST-
Groucho (lane 6). In addition, an internal deletionBMC Cancer 2009, 9:159 http://www.biomedcentral.com/1471-2407/9/159
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Groucho binds to LEF-1 via a motif in the CRD and the HMG DNA binding domain Figure 2
Groucho binds to LEF-1 via a motif in the CRD and the HMG DNA binding domain. A) Glutathione beads bound 
with either GST-Groucho (middle panel) or GST (bottom panel) were tested for interaction with in vitro translated 35S LEF-1 
deletion constructs (translations shown in the top panel refer to deletions depicted in Fig. 1). B) Additional LEF-1 N-terminal 
deletions 1–234 and 1–191 (lanes 2 and 3) were not able to interact with GST-Groucho. Again, LEF-1 1–256 (lane 1) strongly 
interacts with Groucho but a deletion mutant lacking the entire CRD but retaining the HMG (Δ110–295, lane 4) weakly inter-
acts. A GST negative control pull-down shows that LEF-1 does not interact with GST or the beads. Coomassie stained SDS-
PAGE gel of purified GST-Groucho (lane 1) or GST alone (lane 2). C) Amino acid alignment of the putative Groucho binding 
sequence (GBS) and flanking sequences in LEF-1 and other human LEF/TCF family members as well as D. melanogaster and C. 
elegans worm orthologs, pangolin and POP-1 respectively. The LEF/TCF Groucho binding sequence described in this study, FS/
T xxx I/L/V, is similar to the eh1 motif FxIxxIL [20]BMC Cancer 2009, 9:159 http://www.biomedcentral.com/1471-2407/9/159
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removing most of the CRD but retaining the HMG DNA
binding domain, is weaker in its ability to bind GST-Grou-
cho (Figure 2A, lane 5; Figure 2B, lane 4; Δ110–295). A
LEF-1 fragment containing the C-terminal half of the CRD
and the entire HMG domain (237–396) or a fragment
consisting of only the HMG DNA binding domain (296–
396) are equally modest in their ability to bind Groucho
(lanes 7 and 8). Groucho binding is lost only when both
the CRD and the HMG DBD are deleted (Δ237–396)
(lane 6). Taken together, these data suggest there are two
areas of interaction. The primary site is located in the CRD
upstream of amino acid 256 and a second, weaker site of
interaction is in the HMG DNA binding region between
residues 296 and 396. To identify residues most impor-
tant for binding, we tested additional deletions of the
strongest site of interaction in the CRD. C-terminal dele-
tion to amino acids 234 or 192 abrogated binding to GST-
Groucho thus delimiting a 20 amino acid region of recog-
nition: 237-TSMSRFSHHMIPGPPGPHTT-256 (Figure 2B,
C). While this region contains no obvious matches to the
well-known WRPW/Y motif recognized by the Groucho
WD-repeat domain, it shares weak similarity to the eh1
binding motif (FxIxxIL) in that a phenylalanine residue is
present 4 and 5 residues away from two bulky hydropho-
bic residues [17,20]. Eh1 motifs are often recognized by
the WD-repeat domain of Groucho/TLE, but a subset are
recognized by the Q-domain (see Discussion). Weak sim-
ilarities to eh1 via the presence of hydrophic residues in
the middle of this 20 amino acid region does not defini-
tively assign a small recognition motif, but we neverthe-
less hypothesize the main site of recognition to be F S/T/
P xx y I/L/V where x is a histidine, proline or serine (Figure
2C). Even though the entire CRD is poorly conserved
among LEF/TCF family members and orthologs, this cen-
tral hydrophobic sequence is conserved in mammalian,
fly and worm TCFs suggesting that all LEF/TCFs might be
recognized by Groucho in their respective CRDs through
this sequence which we refer to hereafter as the Groucho
Binding Sequence or GBS (Figure 2C).
Groucho and hAES repress LEF-1 mediated activation in 
vivo
Typically, Groucho interacts with transcription factors via
its WD-repeat domain, but in the case of LEF/TCFs, bind-
ing occurs via the Q domain [24,27]. The adjacent GP
domain, which is known to recruit histone deacetylases
(HDACs), is present in truncated Groucho family mem-
bers such as AES (Figure 1; [24,25]). These isoforms con-
tain only the N-terminal Q and GP domains and have
reported actions that vary between either de-repression
(mGrg-5 and XGrg-5) and repression (hAES) [23,26,27].
The differences in repressor or de-repressor function seem
to correlate with sequence differences in the GP domain
and may therefore be the basis for the opposite actions of
the very different mAES and XGrg-5 family members [27].
We compared the ability of LEF-1 to recruit full-length
Drosophila Groucho, human TLE-2 and human AES for
transcription regulation (Figure 3). Using the TopFlash
reporter plasmid, which contains three multimerized Wnt
response elements, we activated transcription by tran-
siently co-transfecting LEF-1 and β-catenin expression vec-
tors in COS-1 cells. Activation by LEF-1￿β-catenin
complexes was equivalently repressed by Groucho, hTLE-
2 and hAES co-repressors two- to three-fold (Figure 3, left
column). Western analysis of transiently transfected Myc-
tagged Groucho, Myc-tagged hTLE-2 or His-tagged hAES
expression vectors in COS-1 cells was performed to con-
firm expression (Figure 3, panel insets). Transcription
repression was specific for each as TOPFlash activity was
reduced whereas there were no significant changes in
activity produced from the negative control FOPFlash, a
reporter that contains 3 multimerized mutant LEF/TCF
binding sites (Figure 3, right column). A co-transfection
control plasmid expressing LacZ is also unaffected by
these conditions. It is notable that Drosophila Groucho is
an equally effective co-repressor for hLEF-1 as human
TLE-2 and human AES, an action that must be function-
ally conserved across species [23,27]. Given our findings
that hAES acts as a co-repressor for LEF-1, we conclude
that recognition of LEF-1 via the Q domain is sufficient for
repression of β-catenin actions and using this validated
assay we then tested whether the delimited region in the
CRD is able to recruit Groucho for transcription repres-
sion in vivo.
Mutation of the Groucho Binding Sequence impairs 
repression in vivo
LEF-1 amino acid substitutions of the GBS were tested for
their potential to disrupt Groucho action in cells. We first
tested a deletion (Δ214–241) which removes alternatively
spliced exon sequences in the CRD (see Figure 1A),
sequences juxtaposed N-terminal to the GBS. This region
has been identified as a HIC5 repressor interaction site
and we wished to test whether the absence of this domain
affected the ability of Groucho to repress [32]. We
observed that deletion of these residues had no effect.
Groucho repression levels were similar to levels with full
length, wildtype LEF-1 (Figure 4, left panel). Thus, alterna-
tive splicing in the upstream region does not affect Grou-
cho/TLE repression in our assay. However, when site
directed mutagenesis was used to change the eight central
amino acids that includes the delimited Groucho Binding
Sequence (241–248; RFSHHMIP to GVALALAA), much of
the Groucho mediated repression was lost (Figure 4, right
panel). Substitution of the neighbouring six residues
(250/255) had no effect on Groucho repression. These inBMC Cancer 2009, 9:159 http://www.biomedcentral.com/1471-2407/9/159
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Groucho and AES repress LEF-1/β-catenin mediated activation of transcription Figure 3
Groucho and AES repress LEF-1/β-catenin mediated activation of transcription. Luciferase activity of a transiently 
transfected TOPFlash reporter assay using COS-1 cells. The TOPFlash (100 ng) reporter with three multimerized LEF/TCF 
DNA consensus sequences in front of the c-fos minimal promoter was activated 5 and 3-fold by LEF-1￿β-catenin complexes 
(200 and 400 ng of expression plasmid respectively). This level of activation was set equal to one for comparison to the amount 
of TOPflash activity measured in the presence of Groucho or AES expression vector (250 and 500 ng as shown). Increasing 
amounts of Groucho or AES expression vector cause increasing repression of reporter activity. All data was normalized with a 
co-transfected CMV β-galactosidase reporter. Error bars represent the standard deviation among three experiments. Student 
t test was performed and p values are represented by asterisks. One asterisk represents a value < 0.05 and two asterisks rep-
resent a value of < 0.01. Western analysis of Groucho, AES and TLE-2 expression shows a dose-dependent increase in protein 
expression (insets).BMC Cancer 2009, 9:159 http://www.biomedcentral.com/1471-2407/9/159
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vivo data are functional confirmation that amino acids
RFSHHMIP (241–248) encompass the core Groucho
binding site.
Groucho mediated repression is HDAC dependent
Groucho/TLE repressors are transcription regulators that
interact with many other co-regulatory factors including
the chromatin modifier HDAC (histone deacetylase), an
interaction that is functionally conserved from flies to
humans [33]. To determine if LEF-1￿Groucho complexes
require HDAC activity for the repression observed in our
assay, we tested whether the HDAC inhibitor trichostatin
A (TSA) could relieve Groucho and/or AES-mediated
repression. The results in Figure 5 show that indeed, TSA
interfered with Groucho and AES repression. TOPFlash
activity was repressed by both Groucho and AES 4–5-fold
in the presence of DMSO. However, reporter activity was
not very well repressed by Groucho or AES in TSA treated
cells (Figure 5; 1.7-fold). Although β-catenin activation of
TOPflash was increased 2.1-fold in the presence of TSA,
this was also true of reporter basal activity which
improved 2.5-fold, suggesting that the core promoter in
this vector is influenced by the actions of HDACs and β-
catenin function is unaffected. These data provide evi-
dence that the transient transfection assay detects Grou-
cho mediated repression through HDAC-dependent
actions. That TSA effects were similar for full-length Grou-
cho and the shorter AES isoform is consistent with previ-
ous reports that HDACs are recruited by the GP domain.
Groucho represses β-catenin action in APC class I mutant 
colon cancer cells
If Groucho uses a co-recruited HDAC activity to oppose β-
catenin￿LEF-1, is this action sufficient to counter endog-
enous β-catenin and its recruited histone acetyltransferase
complexes in colon cancer cells? As previously men-
tioned, a recent study in colon cancer cells suggests that
the switch between β-catenin and Groucho/TLE is com-
plex and is mediated by the tumor suppressor APC [5].
The most common mutations in colon cancer and derived
cell lines result in truncating mutations of the APC pro-
tein. Truncated APC proteins lead to the stabilization of β-
catenin and overactive Wnt signaling because the cyto-
plasmic destruction complex cannot effectively capture
and degrade β-catenin. Elevated levels of β-catenin in the
nucleus might be predicted to influence the dynamics of a
competition with Groucho proteins for binding to endog-
enous LEF/TCFs in cells. However, the ability of Groucho
overexpression to counteract high levels of β-catenin in
colon cancer has never been compared between colon
The Groucho Binding Motif in LEF-1 is necessary for repression Figure 4
The Groucho Binding Motif in LEF-1 is necessary for repression. Luciferase activity in transiently transfected COS-1 
cells. The TOPFlash or Super TOPFlash reporters were co-transfected with the indicated LEF-1 deletion constructs (200 ng) 
and β-catenin (400 ng) with increasing amounts of Groucho expression vector (indicated). Repression is maintained when acti-
vated by LEF-1 lacking the alternative exon (Δ214–241; left panel). Repression is also maintained when residues next to the 
GBM are changed (250/255). Repression is attenuated when all eight residues of the GBM are altered (right panel, center). 
Error bars represent the spread between duplicates and is representative of more than four replicate experiments.
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cancer cell lines. We surveyed Groucho action in a set of
six different lines that differ with respect to mutations in
the APC and β-catenin loci. All cells have higher than nor-
mal levels of LEF/TCF￿β-catenin complexes in the nucleus
due to either stabilizing mutations in β-catenin or loss-of-
function mutations in APC. Type II cell lines (HT-29 cells)
harbour truncating mutations in APC that produce a
shortened APC lacking two nuclear export and nuclear
localization signals (NES; Figure 1) [29,34]. Type I cell
lines (DLD-1, SW480 and Colo320 cells) harbour muta-
tions that severely truncate APC and lack all but two NESs
(Figure 1). The third type (HCT116, LS174T) contains
wildtype APC, but has stabilizing mutations in β-catenin
[35,36]. TLE expression in colon cancer cell lines has been
analyzed by RT-PCR and multiple TLE family members
are expressed in each of these cell lines [27]. Despite the
detection of TLE mRNAs, variations in the levels of TLE
protein could be an important factor in β-catenin activity
in the nucleus. Since the levels and patterns of TLE protein
have never been reported we used whole cell extracts and
a rat monoclonal antisera with pan-TLE specificity to
assess TLE expression by Western blotting [31]. Figure 6A
shows that TLE expression is similar in five of the six cell
lines. DLD1 cells appear to have higher levels of TLE but
the HCT116 cell line has very low levels (longer exposure
of the western blot shows that TLE protein is detected,
data not shown). Therefore at least for HCT116 cells, β-
catenin is in much greater excess relative to total TLE pro-
tein.
Each of these cell lines were transiently co-transfected
with the TOPFlash reporter and increasing amounts of
Groucho expression plasmid. For comparison, TOPFlash
was co-transfected with an expression vector for dominant
negative TCF-1 (dnTCF-1) which competes with endog-
enous LEF/TCF￿β-catenin complexes for binding to the
reporter. We observed significant repression in all of the
type I APC cell lines similar to the negative effects of
dnTCF-1. For example at maximal levels of repression by
Groucho, TOPFlash activity was reduced 3-fold in DLD-1
cells, 2.5-fold in SW480 cells and 5-fold in Colo320 cells
(Figure 6, left). Surprisingly, there was no significant
Groucho repression in APC type II, HT-29 or the APC wild
type, β-catenin mutant, LS174T and HCT116 colon cancer
Groucho and AES recruit HDAC for transcription repression Figure 5
Groucho and AES recruit HDAC for transcription repression. LEF-1￿β-catenin activated TOPFlash was repressed by 
Groucho or AES (1000 ng) via transient transfection in COS-1 cells. Treatment with the HDAC inhibitor trichostatin A (50 ng/
ml) relieved repression. Data is reported as described in Figure 3. Three independent experiments are shown. The error bars 
represent the spread of the duplicates for each experiment.
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cells (Figure 6, right). These data suggest that colon can-
cers may differ in the dynamic interplay between β-cat-
enin and Groucho/TLE such that β-catenin is less opposed
in its actions in some colon cancers and not others.
Discussion
Two interaction domains for Groucho and LEF-1
Groucho/TLEs are described as the main transcription
repressor that opposes Wnt target gene activation, but the
molecular details of their interaction with LEF/TCFs are
not well understood [37]. Our data define a direct interac-
tion between Groucho and LEF-1 as occurring via two
regions, a small region in the context regulatory domain
(aa237-256) and a region in the highly conserved HMG
DNA binding domain (aa296-396). It is not unprece-
dented for Groucho to interact with two regions of a tran-
scription factor. For example, Groucho binds to two
different domains of PAX5 protein via its SP and Q
domains, and to [14,18]. Groucho/TLE functions as a
tetramer and therefore a multimer of Groucho/TLE could
occupy both LEF-1 regions simultaneously (although our
assay could also be detecting independent binding to sep-
arate LEF-1 protein molecules). Chen et al. have shown
that Groucho tetramers can form higher order multimers
with other Groucho tetramers, and Daniels and Weis
demonstrated that recombinant TLE Q fragment indeed
forms tetramers in vitro [24,38]. Thus, these higher order
complexes could easily span the two domains of LEF-1 for
simultaneous binding. In fact, Daniels and Weis have cal-
culated a 4:1 molar ratio for TLE-1/LEF-1 complexes [24].
HMG interactions
The interaction between Groucho and the HMG region
may be indicative of a general feature of HMG domains
since the two HMG boxes of HMGB1 interact with mouse
Grg1 and Grg5 [39]. The interaction we define between
the LEF1 HMG and Groucho is direct via protein/protein
interaction and not mediated by artifactual DNA tethering
since the pulldown assays were performed in the presence
of the DNA intercalating agent Ethidium Bromide. Our
results indicate that the HMG interaction is weak and not
sufficient for Groucho/TLE repression in vivo, because a
deletion mutation that removes the CRD but retains the
HMG DNA binding domain does not support Groucho-
mediated repression (data not shown). Therefore, Grou-
cho requires the CRD for action in vivo. However, we also
tested whether the CRD alone was able to recruit Grou-
cho/TLE for repression. In this case we fused LEF1 coding
sequences for aa1-256, 1–276- and 1–296 to the yeast
Gal4 DNA binding domain and co-transfected these
expression vectors with a reporter plasmid containing 5
multimerized Gal4 binding sites. While we observed
Groucho-mediated repression, the effects were much
more variable than with HMG-based proteins (data not
shown). Therefore an interaction with the CRD may be
the main functional site for Groucho binding, but auxil-
iary interactions with the HMG DNA binding domain
might further stabilize the complex.
GBS interactions
Our in vitro assays were designed to focus on interactions
within the LEF-1 context dependent regulatory domain,
and a 20 amino acid region responsible for much of the
Groucho binding was delimited. Mutation of the central 8
residues in this region eliminated Groucho-mediated
repression in vivo (241–248; Figure 4, right panel). Six of
the eight residues comprise a conserved sequence among
orthologs and family members and we therefore propose
that these 6 residues are the primary site of Groucho bind-
ing and recognition. This sequence, or Groucho Binding
Sequence (GBS) 241-FSHHMI-248, is short like most
Groucho interaction motifs, most notably eh1-motifs
(FxIxxIL) and W/VRPY motifs, in that aromatic and bulky
hydrophobic residues are important. All LEF/TCFs con-
tain a similar GBS-like sequence, and in fact, the analo-
gous sequences in TCF-3 and TCF-4 (Figure 2; FSPHMVA,
FPPHMVP respectively) are comparable to Groucho/TLE
binding motifs in mSix3 and mSix6 transcription factors
(FSPEQVA, FSPQQVA respectively) [22]. Similar to what
has been determined for LEF-1, it is the Q domain that
binds to the Six motifs [18]. It is possible that the GBS is
a variant of eh1, but there are important characteristics
that distinguish it from this class of motif. For example,
while our mutation data show the GBS to be necessary for
Groucho action, an eight amino acid synthetic peptide
containing the GBS was unable to compete with in vitro
translated LEF-1 proteins for GST-Groucho binding, even
when the peptide was provided at high molar excess. In
contrast, eh1 motifs can independently bind to Groucho
either as a purified, synthetic peptide of six amino acids or
as a small fusion to the C-terminus of GST [17]. Either our
synthetic GBS peptide was unable to fold into the appro-
priate conformation or neighbouring residues are
involved in recognition. A requirement for neighbouring
residues may be indeed be important and may be the rea-
son why LEF-1 fragment 237–396 does not bind very well
to Groucho in the in vitro GST-pulldown assay (Figure 2,
lane 7). The GBS is present in this protein fragment, but is
flanked at its N-terminus by only three residues. Protease
protection studies with GST-TLE-1 and LEF-1 show that
Groucho binding protects a region of LEF-1 starting at
amino acid 216, a full 25 residues upstream of the GBS
[24]. It is possible that unlike eh1 and WRPW motifs, an
extended interaction is important for stable binding.
There are other distinguishing characteristics between the
GBS and eh1 motfs. Eh1 peptides adopt alpha helical con-
formations, particularly when bound to the WD-repeat
domain of Groucho [17]. The secondary structure of our
sequence is unknown, but a conserved alpha helical con-BMC Cancer 2009, 9:159 http://www.biomedcentral.com/1471-2407/9/159
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Groucho action in colon carcinoma derived cells Figure 6
Groucho action in colon carcinoma derived cells. A) Western analysis of endogenous TLE expression in colon cancer 
cell lines. Whole cell extracts from the indicated colon cancer cell lines were analyzed by western blotting. Blots were probed 
with rat monoclonal antisera with pan specificity for the TLE family of proteins. Longer exposure of the blot reveals low levels 
of TLE protein in HCT-116 cell line (data not shown). B) Groucho activity was assessed in colon cancer cell lines. SW480, 
Colo320 and DLD-1 cells are type I APC mutant cells (left panels). LS174T, HCT116 and HT-29 cells are wild type APC or 
type II APC mutant cells (right panels). Refer to Figure 1 for the corresponding APC mutations in these cells. TOPFlash 
reporter plasmid was co-transfected with either a dominant negative TCF-1 expression vector (400 ng) or increasing amounts 
of Groucho expression vector. Luciferase activity was assayed 24 hours post transfection and activities normalized to TOP-
Flash reporter alone. The error bars show the standard deviation derived from three independent experiments.
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formation is unlikely as the TCFs and other LEF/TCF
orthologs have helix-breaking proline residues in the mid-
dle of the motif. Also, unlike eh1, it is the Q domain of
Groucho, not the WD repeat domain that is important for
binding.
β-catenin and Groucho competition and HDAC 
requirements
An elegant biochemical and structural study by Daniels
and Weis showed that in addition to binding the N-termi-
nus of LEF-1, β-catenin binds to a second region that
spans the latter half of the protein (252–397) including
the HMG DNA binding domain [24]. They also showed in
this study that Groucho/TLE binding protects a large
region of LEF-1 from aa216 through aa397. Based on
these observations, a model was proposed in which the
overlapping  β-catenin￿HMG interactions competitively
displace Groucho/TLE from LEF-1 for Wnt target gene
activation. Our data shows that Groucho has a primary
binding site of interaction in the CRD (GBS: aa241-248)
distinct from the β-catenin secondary site (aa252-397),
but a site that is closely juxtaposed. Also, the Groucho
auxiliary site lies squarely within the same HMG DNA
binding region protected by β-catenin (aa296-396). Thus,
the competitive displacement model proposed by Daniels
and Weis could be due to steric hindrance of either the pri-
mary or secondary site, or interference with both [24].
Our transient transfection assay, in which both co-activa-
tor β-catenin and co-repressor Groucho are overexpressed,
is primarily an assay for competitive displacement. There-
fore it was surprising that addition of the HDAC inhibitor
TSA caused a significant reduction in the ability of Grou-
cho and AES to compete with β-catenin and repress TOP-
flash expression. Could TSA be destabilizing Groucho
competition for LEF/TCF binding? Groucho/TLE/Grg pro-
teins bind directly to histone tails but not if these tails are
acetylated [33]. This binding ability has been shown to be
important for recruitment and interaction with chroma-
tin-bound transcription factors FoxA1 and Hes1 [40]. Sta-
ble Groucho association with these factors was detected
only when chromatin was unacetylated. Groucho also did
not stably associate when the factors were bound to naked
DNA, or when templates were assembled with tail-less
histone H3 and H4 nucleosomes, or when assembled
with highly acetylated chromatin [40]. The exact nature of
chromatin assembled on transiently transfected plasmids
is unknown, but partial chromatinization and semi-regu-
lar arrays of nucleosomes are likely to be present [41-43].
Perhaps in our system the TSA-sensitive HDAC activity is
essential for deacetylating chromatin to enable stabilized
Groucho interactions with DNA-bound LEF-1 and neigh-
boring nucleosomes. Stabilized interactions might be nec-
essary for Groucho to effectively displace β-catenin. Since
one of the hallmarks of β-catenin action is chromatin
acetylation, we favor a model that without co-recruited
HDAC activity, Groucho binding to DNA-bound, β-cat-
enin-occupied LEF/TCFs is tenuous and transient and β-
catenin wins the competition for LEF-1 occupancy. Grou-
cho/TLE proteins have additional maintenance actions on
chromatin and transcription such as nucleosome-based
spreading and chromatin compaction, but it is not very
likely that our transfection assay is assessing these more
long-term activities.
Variations in Groucho activity in colon cancer cell lines
Groucho suppression of Wnt signaling would be reduced
if its binding to LEF/TCFs were impaired, or as our data
show, its ability to utilize HDAC activity were prevented.
Many cancers have elevated Wnt signaling, but so far, no
mutations in the CRD of any LEF/TCF have been reported
and no mutations in Groucho/TLE or HDACs have ever
been described. Instead, the majority of colon cancers har-
bour truncating mutations in APC or stabilizing muta-
tions in β-catenin. Mutations in APC might have
important bearing on Groucho action because at least one
recent study has shown that APC can facilitate displace-
ment of β-catenin and association of TLE-1 at an endog-
enous Wnt target gene [5]. In this study, HT-29 colon
cancer cells with truncated APC have LEF-1/β-catenin
complexes constitutively occupying a WRE in the cMYC
enhancer. When wildtype, full-length APC was inducibly
expressed in these cells, nuclear localization and associa-
tion of the overexpressed wildtype APC with the chroma-
tin-bound LEF-1 complex was detected [5]. This
association with LEF-1 was transient and preceded rapid
displacement and exchange of β-catenin for TLE-1 [5].
Based on these observations a two-step model was pro-
posed whereby APC mediates the competition and
exchange between the co-activator β-catenin and the co-
repressor Groucho/TLE for LEF/TCF binding.
To further investigate the role of APC in repression, we
tested the ability of Groucho to repress TOPFlash activity
in colon cancer cell lines with wild type or variant APC
proteins, predicting that Groucho would not be able to
oppose β-catenin actions in cell lines with truncated APC
proteins. Surprisingly, our data suggests the opposite.
Groucho activity is most evident in cell lines with trun-
cated APC protein. While the underlying mechanism for
this is unknown, a survey of the literature reveals that APC
localization differs in colon cancer cells lines but follows
a trend based on APC length. Specifically, the HT-29
colon cancer cell line has a type II APC truncation muta-
tion and the LS174T and HCT116 cell lines have a full
length, wild type APC protein [34]. Each of these cell lines
have predominantly cytoplasmic APC [29]. Conversely,
DLD-1, SW480 and Colo320 colon cancer lines have high
levels of nuclear APC; all of these lines have type I muta-
tions that result in significantly truncated APC proteinBMC Cancer 2009, 9:159 http://www.biomedcentral.com/1471-2407/9/159
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[44-47]. Interestingly, the type II and wild type APC pro-
teins retain three of five NES sequences and the type I APC
mutations retain only two NES sequences (Figure 1).
Although both NLS sequences are located in the C-termi-
nus, mutants lacking this region are still localized in the
nucleus, a localization that might be due to its association
with nuclear β-catenin [29].
Our results suggest that nuclear APC predicts effective
Groucho/TLE repression. Thus, the observation in HT-29
cells where induced expression of wildtype APC clears β-
catenin from Wnt Response Elements could be due to the
fact that overexpression of APC forces greater levels of its
nuclear concentration [5]. Our data also point to addi-
tional abnormalities. HCT116 cells have very low levels of
total TLE protein, as determined by western blot with pan-
TLE-specific antibody (Figure 6A). These low levels may
be due to TLE protein instability because TLE mRNA is
present [27]. We transiently overexpressed hTLE2 in these
cells as a positive control but were unable to detect hTLE2
protein on a western blot (data not shown). Therefore the
lack of Groucho action in HCT116 cells might be due to
the fact that TLE proteins are unstable in this cell line. This
unexpected observation suggests that TLE protein levels
and stability may vary in colon tumors and cell lines.
Conclusion
We conclude that Groucho/TLE repression of β-catenin
association and action with LEF/TCFs requires two sites of
interaction. The primary site of Groucho interaction is a
short conserved amino acid sequence in the context
dependent regulatory domain. Repression requires his-
tone deacetylase activity suggesting multiple components
are involved in Groucho competition with β-catenin. The
variable ability of Groucho/TLE to oppose Wnt signaling
in colon cancer cells suggests defects exist in one or more
steps of the pathway.
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